William H. Fiske, M.D.

Assistant Professor

haley.fiske@vanderbilt.edu
Faculty Appointments
Assistant Professor of Medicine
Education
M.P.H., Public Health , Vanderbilt University, Nashville, TennesseeM.D., Medicine , Vanderbilt University, Nashville, TennesseeB.S., Duke University, Durham, North Carolina
Office Address
1501 TVC
TN
Publications
Rich A, Toro TZ, Tanksley J, Fiske WH, Lind CD, Ayers GD, Piessevaux H, Washington MK, Coffey RJ. Distinguishing Ménétrier's disease from its mimics. Gut [print-electronic]. 2010 Dec; 59(12): 1617-24. PMID: 20926644, PMCID: PMC3020399, PII: gut.2010.220061, DOI: 10.1136/gut.2010.220061, ISSN: 1468-3288.

Fiske WH, Tanksley J, Nam KT, Goldenring JR, Slebos RJ, Liebler DC, Abtahi AM, La Fleur B, Ayers GD, Lind CD, Washington MK, Coffey RJ. Efficacy of cetuximab in the treatment of Menetrier's disease. Sci Transl Med. 2009 Nov 11/25/2009; 1(8): 8ra18. PMID: 20368185, PMCID: PMC3638759, PII: 1/8/8ra18, DOI: 10.1126/scitranslmed.3000320, ISSN: 1946-6242.

Fiske WH, Threadgill D, Coffey RJ. ERBBs in the gastrointestinal tract: recent progress and new perspectives. Exp. Cell Res [print-electronic]. 2009 Feb 2/15/2009; 315(4): 583-601. PMID: 19041864, PMCID: PMC2941795, PII: S0014-4827(08)00450-3, DOI: 10.1016/j.yexcr.2008.10.043, ISSN: 1090-2422.

Settle SH, Washington K, Lind C, Itzkowitz S, Fiske WH, Burdick JS, Jerome WG, Ray M, Weinstein W, Coffey RJ. Chronic treatment of Ménétrier's disease with Erbitux: clinical efficacy and insight into pathophysiology. Clin. Gastroenterol. Hepatol. 2005 Jul; 3(7): 654-9. PMID: 16206497, ISSN: 1542-3565.